Silhouette
Upgrade to view details

John A Rathmacher

Metabolic Technologies, Inc.

Message

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $151K 09/30/17 05/31/18
Nutritional Intervention for Age-Related Muscular Function and Strength Losses
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $97.7K 07/15/17 02/28/18
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $684K 07/01/17 05/31/18
2-Hydroxybenzylamine for the prevention of Alzheimer's disease: Initial evaluation in humans
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $672K 09/30/16 05/31/17
Nutritional Intervention for Age-Related Muscular Function and Strength Losses
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $375K 03/01/16 02/28/17
Gamma-ketoaldehyde scavengers for alcoholic liver disease
Metabolic Technologies, Inc.
Principal Investigator
HHS 1 $152K 09/25/14 02/28/15
Nutritional Intervention for Age-Related Muscular Function and Strength Losses
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $375K 03/15/14 02/28/15
SBIR Phase I: Metabolic Engineering of Moritella marina MP-1 for DHA Production
Metabolic Technologies, Inc.
Principal Investigator
NSF 1 $150K 01/01/13 12/31/13
Nutritional Intervention for Age-Related Muscular Function and Strength Losses
Metabolic Technologies, Inc.
Principal Investigator
HHS 2 $100K 07/01/10 12/31/12
Adjuvant Nutrition for Critically III Trauma Patients
Metabolic Technologies, Inc.
Principal Investigator
HHS 1 $100K 02/01/03 07/31/04
Body Protein Metabolism and Nutrition in Aids-wasting
Metabolic Technologies, Inc.
Principal Investigator
HHS 1 $98.9K 09/29/00 03/28/02